The 3rd Global Symposium on Interferon Gamma Release Assays (IGRAs), held in January 2012, provided an opportunity for clinicians and researchers to discuss the dynamics of tuberculosis (TB) infection, tools to diagnose and manage TB, and methods to assess clinical problems related to the disease.
This activity is a 50 minute video discussion of highlights presented at the symposium, and focuses on latent TB infection and the use of IGRAs in monitoring new infections, particularly healthcare workers.
Upon completion of this activity, participants should be able to:
This activity is designed for academic physicians, specialty physicians such as those who practice infectious disease, pulmonary medicine, pediatrics as well as public health officials, practitioners of occupational medicine and other healthcare providers who care for patients at risk for tuberculosis.
Method of Participation
The estimated time to complete this activity is 1-hour. To obtain credit, participants should take a brief pre-activity survey, view the activity video, answer the multiple-choice post test questions, and complete the evaluation form online to receive a certificate immediately upon completion.
The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA: The University of California, San Diego School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hour of Category 1 credit for completing this program.
Release Date: December 7, 2012
Antonino Catanzaro, MD
Charles L. Daley, MD
Michael D. Iseman, MD
Luca Richeldi, MD, PhD
Balance and Objectivity of Content
It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual's control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speaker's outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.
The following faculty have reported relevant financial relationships:
Antonino Catanzaro, MD: Board Member for Cellestis, Inc.
Michael Iseman, MD: Consultant/Stock Shareholder for Oxford Immunotec
Luca Richeldi, MD, PhD: Grant/Research Support for ADA
The following faculty indicated they have no financial relationships with commercial interests relevant to the content of this activity:
Charles Daley, MD
The CME staff, meeting planners, editorial staff, planning committee, peer reviewer and CME committee reviewers do not have any relevant financial relationships to disclose.
Off-label Disclosure: This educational activity may contain discussion of unlabeled and/or investigational uses of agents that are not approved by the FDA. Please consult the prescribing information for each product.
The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California, San Diego.
This activity is in compliance with California Assembly Bill 1195 which requires CME courses with patient care components to include curriculum in the subjects of cultural and linguistic competencies. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient's primary language. Cultural and Linguistic Competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about AB1195 can be found on the UC San Diego CME website at cme.ucsd.edu
Supported by an educational grant from Cellestis